In a mouse model, dicloxacillin-coated polyurethane catheters or control (uncoated) catheters were placed subcutaneously and then Staphylococcus aureus was inoculated at the time of insertion, 24 or 48 h later. The in vivo half-life of the antibiotic was 11 to 16 h. When 105 CFU of S. aureus were inoculated at the time of catheter insertion, dicloxacillin-coated catheters kept the number of S. aureus removed from catheters by sonication below 102 CFU at 12, 24, 48, and 96 h after inoculation compared with titers greater than 103-5 CFU for control catheters (P < 0.05). When S. aureus was inoculated 24 h after catheter insertion, control catheters averaged greater than 102 CFU of S. aureus removed compared with less than 101-5 CFU for the dicloxacillin-coated catheters (P < 0.05). No difference was found between coated and control catheters when S. aureus was inoculated 48 h after catheter insertion, but S. aureus titers averaged less than 102 CFU for all experimental groups. Our data suggest that in mice, regional prophylaxis of S. aureus subcutaneous space infection is feasible with catheters coated with dicloxacillin and that the presence of antibiotic is only necessary for the first 24 to 48 h.
Catheter-related vascular infection continues to be an important cause of morbidity and mortality for patients requiring vascular access. These infections are most commonly caused by staphylococci-either coagulase-negative staphylococci or Staphylococcus aureus (7, 8) . Infections caused by coagulase-negative staphylococci are frequently mild and easily treated by either removing the catheter or a course of antibiotics with the catheter in place (2, 21) . S. aureus infections are usually more serious and require removal of the catheter and extended antibiotic therapy (9, 20) . Because of the greater clinical impact of S. aureius infections, we became interested in whether such infections were preventable.
S. aureus produces vascular access infection primarily by multiplication of the organism on the skin at the catheter insertion site followed by growth of the organism along the subcutaneous tunnel of the catheter (1, 13) . This information suggests that a reduction in the number of S. auireius at the insertion site can reduce the likelihood of infection. Zinner et al. (22) have demonstrated in humans that it is possible to reduce the incidence of insertion site colonization with S. aureus with a topical polymyxin-neomycin-bacitracin ointment. More to the point, Trooskin et al. (19) were able to prevent S. aureus infection in rats by the use of polyethylene catheters coated with penicillin G.
These reports encouraged us to investigate the effect of catheter-bound antibiotic on S. aureus infection in a mouse model of foreign body infection. Using ionic binding techniques, it was possible to bind dicloxicillin to polyurethane catheters, resulting in an in vivo half-life of 11 to 16 h. These catheters were able to prevent infection from occurring if S. aureus was inoculated at the time of catheter insertion or 24 or 48 h later. Our data provide additional evidence that catheter-bound antibiotic has the potential to reduce the incidence of S. aureuis vascular access infection.
MATERIALS AND METHODS
Binding of antibiotics. Three methods were employed by Becton Dickinson Polymer Research (Dayton, Ohio) to bind dicloxacillin (Bristol Laboratories, Syracuse, N.Y.) to 16-gauge Vialon polyurethane catheters (18) . In the first method, dicloxacillin was complexed with a quaternary ammonium (QA), and two concentrations of this complex (D-QA) were used to coat catheters (type 1, low; type 2, high). In the second method, a low-molecular-weight polyurethane plus the D-QA complex were used in solution to coat catheters. Two concentrations of the low-molecularweight polyurethane were employed (type 3, low; type 4, high). In the third method (type 5), catheters were first coated with a solution containing the D-QA complex plus the low-molecular-weight polyurethane followed by a second coating with the D-QA complex. After preparation, each catheter was placed in an individual packet, sterilized, and stored for later use.
In vitro catheter antibiotic activity. Half-lives were calculated by the relationship: t1/2 = -0.301/slope. The slope in this equation is generated by first converting the agar zone sizes to log 10 and then performing linear regression with zone size as the y coordinate and time in vivo as the x coordinate.
Mouse model of S. aureus infection. Mice were prepared as in the in vivo half-life experiments and then inoculated (50 or 100 iil) with either phosphate-buffered saline alone or phosphate-buffered saline plus 105 to 106 CFU of S. aureus subcutaneously next to the catheter. In the first experiment, dicloxacillin-coated catheters were compared with control catheters for their effect on S. aureus inoculated at the time of catheter insertion. In the second experiment, two types of coated catheters (type 1 and 5) were compared with control catheters for their effect on S. aureus inoculated 24 h after the catheters were inserted. In the final experiment, the same two coated catheters and control catheters were used with S. aureus inoculated 48 h after the catheters were inserted. In all three experiments, 8 to 10 mice were evaluated for each catheter type at each time interval.
Catheter harvesting. Mice were sacrificed by cervical dislocation, and the catheters were aseptically removed. Each catheter was placed in 4 ml of Trypticase soy broth and sonicated for 3 min in a water bath sonicator (100 W, 80,000 Hz; Ultrasonic Industries, Inc., Plainview, N.Y.). The broth was serially diluted and surface plated on Trypticase soy agar to determine the number of bacteria removed from each catheter. Each catheter was then placed in Trypticase soy broth and incubated overnight at 37°C to assess whether any bacteria remained on the catheter. A swab of the subcutaneous pocket was plated on blood agar, and the percentage of hemolytic colonies was used to correct the total organism counts obtained from the sonication method to give a more accurate representation of the number of S. aureus. For example, if 90% of the colonies were hemolytic and looked like S. aureus, then the final count would be multiplied by 0.9 to correct for possible contamination. In addition, the counts were used to provide another measure of the number of S. aureus in the subcutaneous catheter pocket.
Statistics. Owing to a wide range in the number of organisms removed from catheters placed subcutaneously, all organism counts were converted' to log 10 so that the means of these numbers would be geometric means. (18) . For a 30-g mouse, this is equivalent to a total body dose of 0.5 mg/kg. This dicloxacillin activity was stable for greater than 1 month when the catheters were stored in desiccated individual plastic packets. No zone was produced when either the QA or the low-molecular-weight polyurethane or both were placed on the catheters without dicloxacillin.
In vivo catheter antibiotic half-life. The in vivo antibiotic half-lives of type 1, 2, and 5 dicloxacillin-coated catheters have been estimated graphically and reported previously as 12, 12, and 24 h, respectively (18) . The actual calculated half-lives based on the slopes of the regression lines for all five catheter types studied were as follows: type 1, 11.4 ± 0.5 (standard deviation) h; type 2, 12.8 ± 1.1 h; type 3, 12.3 ± 0.6 h; type 4, 12.7 ± 0.8 h; and type 5, 16.2 ± 1.8. The correlation coefficients (r) calculated from the regression analyses were quite high, ranging from 0.92 to 0.98. Type 1 through 4 coated catheters had no measurable activity after 48 h. Type 5 had significantly greater zone sizes than all four of the other catheters at 12, 24, 48, and 96 h (P < 0.05).
S. aureus had no effect on in vivo half-life with type 1 catheters (Fig. 1) of type 1 catheters and 0% (0 of 6) of type 5 catheters were culture negative by broth testing and had associated negative swab cultures versus 0% (0 of 10) of control catheters.
In the final experimental group, S. aureus was inoculated 48 h after the catheters were implanted (Fig. 4) . Control catheter S. aureius titers were significantly lower than those obtained with a zero hour inoculation (at 12, 24, 48, and 96 h, P < 0.05; Mann-Whitney), and a significant proportion of these animals had sterile catheters without exposure to antibiotics (Table 1) . At 96 h after S. aureus inoculation, 43% (3 of 7) of type 1 catheters and 63% (5 of 8) of type 5 catheters were culture negative by broth culture and had associated negative swab cultures versus 30% (3 of 10) of control catheters. In this group, it was not possible to show any clear differences between the control catheters and the antibiotic-coated catheters. This may be due more to the difficulty in producing an infection than to a lack of antibiotic activity.
No abscesses were seen around the catheters whether the S. aureus was inoculated at 0, 24, or 48 h after the catheters were inserted. DISCUSSION S. aureus catheter-related vascular infections continue to be an important problem for patients requiring vascular (4, 12, 17) . These infections may require prolonged treatment owing to the associated occurrence of endocarditis (14, 20) . Although uncommon, death may occur related to these infections (14, 17) . Catheter insertion for vascular access can be considered analogous to a surgical procedure. High infection rates associated with surgical procedures can usually be lowered by using prophylactic antibiotics (15) . Since existing vascular access infection rates occur in the setting of topical antibiotic use, any further decrease in infection rates will most likely result from some additional route of antibiotic delivery. While systemic prophylactic antibiotics have been shown to work with vascular graft infections, no one has investigated the use of systemic antibiotics to prevent vascular catheter infection (11, 16) . However, there are data suggesting that the use of regionally delivered antibiotics (i.e., catheter-bound antibiotic) is effective at decreasing vascular infection (6, 19) .
Trooskin et al. (19) have demonstrated that penicillin G can be bound to polyethylene catheters by using the quaternary amine tridodecylmethylammonium chloride. When inserted in the jugular veins of rats, these catheters were capable of preventing catheter colonization for 5 days after challenge with 108 S. aureus (O of 10 animals). In contrast, untreated control catheters were significantly more likely to be colonized ( (10) with silk and cotton sutures in a mouse model of S. aureus stitch infection. However, in this same model nylon sutures were 1,000-fold less likely to produce a purulent infection. Given the marked differences between suture materials in their predisposition to purulent infection, it is very possible that polyurethane catheters have a low risk of infection associated with them analogous to nylon sutures. Further work is necessary to determine whether dicloxacillin will have an effect in a more virulent model of S. aureus infection.
A new concept that is suggested by this study is that the longer the catheter resided in the mouse prior to organism inoculation, the more difficult it was to produce an infection. When S. aureus was inoculated 48 h after a control catheter was inserted, 40% of the catheters removed 96 h later were sterile versus 0% if the organisms were inoculated at the time of insertion (Table 1) . If this consideration applies to human vascular access sites, it implies that preventing the multiplication of S. aureus in the catheter-created wound during the first few days after insertion could reduce the likelihood of S. aureus infection. Substantiation of this finding would provide a very strong theoretical argument for the use of prophylactic antibiotics with vascular catheters. Our data in mice indicate that catheter-bound antibiotic is one way to accomplish this prophylaxis.
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